Ocanacatib antifracture efficacy and saftey in postmenopausal women with osteoporosis: results from the phase III long-term adonacatib fracture trial (LOFT)McClung, A. Lombardi, T. de Villiers et al.|Open Repository and Bibliography (University of Liège)|2015Cited by 3
Safety and tolerability of odanacatib therapy in postmenopausal women with osteoporosis: results from the phase III long-term odanacatib fracture trialSocrates E. Papapoulos, Deborah M. Gurner, McClung et al.|Open Repository and Bibliography (University of Liège)|2014Cited by 2
Denosumab for prevention of fractures in postmenopausal women with osteoporosis. Editorial commentCummings, C. Christiansen, J E Martin et al.|Unknown|2009Cited by 0